Medical Services

Modern discipline known as molecular oncology examines the genetic and molecular basis of cancer to enable precision medicine. Oncologists can find certain changes causing cancer development by examining genetic mutations, gene expression, and molecular pathways in tumours. This thorough knowledge makes it possible to create focused treatments—drugs meant to kill cancer cells depending on their individual genetic profiles while preserving healthy tissue.
Common mutations in genes including EGFR, HER2, ALK, BRAF, and KRAS direct treatment in malignancies including lung, breast, colonical, and melanoma. Actionable mutations are found by methods including liquid biopsy and next-generation sequencing (NGS). These instruments enable patients to be matched with medications that are more likely to be successful and help lower unneeded side effects.
Targeting monoclonal antibodies, tyrosine kinase inhibitors, and immunotherapies gives patients with once challenging-to-treat tumours fresh hope. Monitoring therapy response and identifying resistance mechanisms also depend on molecular oncology.
With this tailored approach to cancer treatment, patients all over will have better quality of life and survival rates—a major improvement over past years.